Cortical Plasticity Assessment in Athletes With a History of Concussion
23. april 2020 oppdatert av: Felipe Fregni, Spaulding Rehabilitation Hospital
The purpose of this research is to determine whether athletes with concussion have changes in cortical excitability.
Single and paired transcranial magnetic stimulation (TMS) can be used as reliable neurophysiological marker of motor cortex reorganization in athletes with concussions.
This study also aims to determine whether modulation of cortical activity by a powerful technique of noninvasive brain stimulation (tDCS) results in a different cortical response as compared with sham tDCS.
Studieoversikt
Status
Avsluttet
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This study is a multicenter study with investigators from other institutions (Dr.
Alvaro Pascual-Leone and Dr. Hugo Theoret).
Studietype
Intervensjonell
Registrering (Faktiske)
1
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater
- Spaulding Rehabilitation Hospital
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år til 30 år (Voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Student-athletes at risk for traumatic brain injury (collegiate football, ice hockey)
- Age between 18 and 30 yr.
- Concussion as defined by the American Academy of Neurology: trauma-induced alteration in mental status that may or may not involve loss of consciousness (confusion and amnesia are the hallmarks of concussion)
- Concussion that occurred > 6 months
- All head injuries classified as minor with a Glasgow Coma Scale of 13 to 15 at the time of the trauma
- Participants are cleared for full sport participation based upon neurological and neuropsychological (NS) assessments Classified as symptomatic based on Post-concussion Symptom List
Exclusion Criteria:
- Previous significant neurological history
- Use of tricyclic anti-depressants such as amitriptyline, nortriptyline and imipramine within the past six months.
- Use of anticonvulsants such as carbamazepine, phenytoin, valproic acid and gabapentin within the past six months
- History of seizures, depression or PTSD
- Presence of post-concussion symptoms such as complaints of loss of concentration, dizziness, fatigue, headache, irritability, visual disturbances, and light sensitivity.
- Contraindications to single pulse TMS (TMS will be used to measure cortical excitability) such as metal head implants
- history of seizures
- unexplained loss of consciousness
- metal in the head
- frequent or severe headaches or neck pain
- implanted brain medical devices.
- Contraindications to tDCS:
- metal in the head
- implanted brain medical devices
For the control group (subjects with no concussion) we will select subjects according to the previously stated list of exclusions as well as the following criteria: Subjects who are athletes (similar to the concussed group) with the same age range and also similar level of education; however these subjects will have no prior history of concussion or neurological insult as self reported. They should also have no contraindications to TMS or tDCS.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Healthy Subjects
Each subject will undergo each of the three conditions (active anodal tDCS, cathodal tDCS and sham tDCS), but the order in which they do so will be randomized.
|
Each type of stimulation will be administered with a time interval of a week in between to prevent any carryover affects.
|
|
Eksperimentell: Athletes with history of concussion
Each subject will undergo each of the three conditions (active anodal tDCS, cathodal tDCS and sham tDCS), but the order in which they do so will be randomized.
|
Each type of stimulation will be administered with a time interval of a week in between to prevent any carryover affects.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Cortical excitability and cortical plasticity assessment
Tidsramme: Baseline, 1st, 2nd and 3rd week
|
TMS and tDCS
|
Baseline, 1st, 2nd and 3rd week
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Cognitive functioning in athletes with concussion compared to athletes without concussion
Tidsramme: Baseline, 1st, 2nd and 3rd week
|
Will use the Immediate Postconcussion Assessment and Cognitive Test (IMPACT): a neuropsychological test battery that measures aspects of cognitive functioning including attention, memory, reaction time and information processing speed.
|
Baseline, 1st, 2nd and 3rd week
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Felipe Fregni, PhD, Spaulding Rehabilitation Hospital
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. april 2010
Primær fullføring (Faktiske)
1. april 2013
Studiet fullført (Faktiske)
1. april 2013
Datoer for studieregistrering
Først innsendt
20. april 2010
Først innsendt som oppfylte QC-kriteriene
27. april 2010
Først lagt ut (Anslag)
28. april 2010
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
24. april 2020
Siste oppdatering sendt inn som oppfylte QC-kriteriene
23. april 2020
Sist bekreftet
1. april 2020
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 2010P000191
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .